Last Update Time:
19-Mar-2025 12:57:51
ISIN:
INE681B01017
Sector:
Healthcare
Symbol:
INDRAMEDCO
Indraprastha Medical Corporation Limited
₹386.55
₹31.55
(8.89%)
▲
Prev. Close
₹355.00
Open
₹359.00
Close
₹0.00
Range
₹367.22 - ₹405.88
High
₹390.50
Low
₹358.10
Ind. Close
₹0.00
VWAP
₹380.06
The current stock price of Indraprastha Medical Corporation Limited is ₹386.55, with a target price range between ₹367.22 and ₹405.88. The stock has experienced a price change of ₹31.55 (8.89%), reflecting recent market volatility.
Today's opening price was ₹359.00, while the previous close stood at ₹355.00.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Indraprastha Medical Corporation Limited Price Chart
Indraprastha Medical Corporation Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 359
- Previous Close Price: 355
- Change: 4.00%
- Total Traded Volume: 1,859
- Total Buy Quantity: 10,043
- Total Sell Quantity: 15,047
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 355.00 | 680.00 | 0.00 |
| 356.80 | 300.00 | 0.00 |
| 357.40 | 60.00 | 0.00 |
| 358.00 | 100.00 | 0.00 |
| 358.20 | 5.00 | 0.00 |
| 359.00 | 0.00 | 80.00 |
| 359.25 | 0.00 | 5.00 |
| 359.45 | 0.00 | 205.00 |
| 359.75 | 0.00 | 53.00 |
| 359.85 | 0.00 | 46.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 386.15 | 17 | 386.60 | 11 |
| 386.10 | 13 | 386.75 | 57 |
| 386.05 | 52 | 386.90 | 33 |
| 386.00 | 158 | 386.95 | 36 |
| 385.80 | 1 | 387.00 | 64 |
Total Buy Quantity: 10043
Total Sell Quantity: 15047
Shareholding Patterns of Indraprastha Medical Corporation Limited
Key Trade Statistics of Indraprastha Medical Corporation Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 5.40 |
| Traded Value (₹ Cr.) | 20.51 |
| Total Market Cap (₹ Cr.) | 3,543.62 |
| Free Float Market Cap (₹ Cr.) | 1,703.78 |
| Impact cost | 0.11 |
| Quantity Traded | 517,916.00 |
| Deliverable Quantity | 217,096.00 |
| % of Quantity to Traded | 41.92 |
| Security VaR | 21.96 |
| Index VaR | N/A |
| VaR Margin | 21.96 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 25.46 |
| Face Value | 10 |
Key Price Statistics of Indraprastha Medical Corporation Limited
The 52-week high for Indraprastha Medical Corporation Limited was ₹572.00, recorded on 08-Jan-2025. On the other hand, the 52-week low stands at ₹161.55, with the lowest value recorded on 27-Mar-2024.
The upper band for trading is ₹426.00, and the lower band is ₹284.00. The price band is 20%.
The stock's daily volatility stands at 3.26, while the annualized volatility is 62.28. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (08-Jan-2025) | 572.00 |
| 52 Week Low (27-Mar-2024) | 161.55 |
| Upper Band | 426.00 |
| Lower Band | 284.00 |
| Price Band (%) | 20 |
| Daily Volatility | 3.26 |
| Annualised Volatility | 62.28 |
| Tick Size | 0.05 |
Key Securities Statistics of Indraprastha Medical Corporation Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 17-Apr-1997 |
| Adjusted P/E | 21.53 |
| Symbol P/E | 21.53 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Hospital |
Security Status of Indraprastha Medical Corporation Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Indraprastha Medical Corporation Limited
| Subject | Date |
|---|---|
| Copy of Newspaper Publication | 04-Feb-2025 |
| Integrated Filing- Financial | 03-Feb-2025 |
| Financial Result Updates | 03-Feb-2025 |
| Copy of Newspaper Publication | 01-Feb-2025 |
| Loss/Duplicate-Share Certificate-XBRL | 31-Jan-2025 |
| Loss of Share Certificates | 31-Jan-2025 |
| Board Meeting Intimation | 21-Jan-2025 |
| Integrated Filing- Governance | 21-Jan-2025 |
Corporate Actions of Indraprastha Medical Corporation Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting/Dividend - Rs 4.50 Per Share | 13-Sep-2024 |
| 10 | Annual General Meeting/Dividend - Rs 3 Per Share | 15-Sep-2023 |
| 10 | Annual General Meeting/Dividend - Rs 2.50 Per Share | 15-Sep-2022 |
| 10 | Annual General Meeting | 16-Sep-2021 |
| 10 | Annual General Meeting | 17-Sep-2020 |
| 10 | Annual General Meeting/Dividend - Rs 1.60 Per Sh | 12-Sep-2019 |
| 10 | Annual General Meeting/Dividend- Rs 1.50 Per Share | 12-Sep-2018 |
| 10 | Annual General Meeting/Dividend - Rs 1.80 Per Share | 14-Sep-2017 |
| 10 | Annual General Meeting/ Dividend - Rs 1.80/- Per Share | 18-Aug-2016 |
| 10 | Annual General Meeting / Dividend Rs 1.80/- Per Share | 16-Sep-2015 |
| 10 | Annual General Meeting / Dividend - Rs 1.80/- Per Share | 18-Sep-2014 |
| 10 | Annual General Meeting / Dividend - Rs 1.60/- Per Share | 19-Sep-2013 |
| 10 | Annual General Meeting And Dividend Rs.1.60 Per Share | 06-Sep-2012 |
| 10 | Dividend Rs 1.60 Per Share | 05-Sep-2011 |
| 10 | Annual General Meeting And Dividend Rs.1.60 Per Share | 30-Aug-2010 |
| 10 | Dividend-Rs.1.50 Pr Share | 27-Aug-2009 |
| 10 | Agm/Dividend - 14% | 28-Aug-2008 |
| 10 | Agm/Dividend-12.5% | 07-Sep-2007 |
| 10 | Agm/Dividend-12.5% | 28-Jul-2006 |
| 10 | Agm/Dividend-10% | 18-Aug-2005 |
Board Meetings of Indraprastha Medical Corporation Limited
Financial Results of Indraprastha Medical Corporation Limited
Company Directory of Indraprastha Medical Corporation Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Registered Office | Sarita Vihar Delhi - Mathura Rd., | NEW DELHI |
| N/A | Transfer Agent | Link Intime India Private Limited 44, Community Centre, Phase - I, 2nd Floor, Naraina Industrial Area, Near PVR Naraina | NEW DELHI |
Insider Trading of Indraprastha Medical Corporation Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
|---|---|---|---|---|---|
| No insider trading information available | |||||
Annual Reports of Indraprastha Medical Corporation Limited
Investor Complaints of Indraprastha Medical Corporation Limited
Event Calendar of Indraprastha Medical Corporation Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To consider and approve, the audited financial results for the quarter / year ended March 31, 2011, and to consider and recommend dividend on equity shares of the Company for the financial year 2010-11. |
| Results/Dividend | To consider and approve, the audited financial results for the quarter / year ended March 31, 2012, and to consider and recommend dividend on equity shares of the Company for the financial year 2011-12. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended December 31, 2012. |
| Results/Dividend | To consider and approve, the audited financial results for the quarter / year ended March 31, 2013, and to consider and recommend dividend on equity shares of the Company for the financial year 2012-13. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended June 30, 2013. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended September 30, 2013. |
| Board meeting Rescheduled | The Company had informed the Exchange regarding Board Meeting to be held on November 06, 2013 to consider and approve the Unaudited Financial Results for the quarter ended September 30, 2013. The Company has now informed the Exchange that the aforesaid meeting has been rescheduled and it will be held on November 11, 2013. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended December 31, 2013. |
| Results/Dividend | To consider and approve, the audited financial results for the quarter / year ended March 31, 2014, and to consider and recommend dividend on equity shares of the Company for the financial year 2013-14. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended June 30, 2014. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended September 30, 2014. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended December 31, 2014. |
| Results/Dividend | To consider and approve, the audited financial results for the quarter/ ' year ended March 31, 2015, and to consider and recommend dividend on equity shares of the Company for the financial year 2014-15. |
| Board Meeting Postponed | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held May 25, 2015 To consider and approve, the audited financial results for the quarter/ year ended March 31, 2015, and to consider and recommend dividend on equity shares of the Company for the financial year 2014-15.The Company has now informed the Exchange that the meeting of the Board of Directors has now been postponed to May 26, 2015 (Revised). |
| Results | For declaration of Financial Results for the quarter ended June 30, 2015. |
| Results | to consider and approve the unaudited Financial Results for the quarter ended September 30, 2015. |
| Results | To consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2015. |
| Results/Dividend | inter alia :-(i) to consider and approve, the audited financial results for the quarter/ year ended March 31, 2016, and (ii) to consider and recommend dividend, if any, on equity shares of the Company for the financial year 2015-16. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended June 30, 2016. |
| Results | To consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2016. |
| Board Meeting Postponed | INDRAMEDCO : 22-Nov-2016 : The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held November 15, 2016, to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2016. The Company has now informed the Exchange that the meeting of the Board of Directors has now been postponed to November 22, 2016 (Revised). |
| Results | To consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2016. |
| Results/Dividend | inter alia :- to consider and approve, the audited financial results for the quarter/ year ended March 31, 2017, and to consider and recommend dividend, if any, on equity shares of the Company for the financial year 2016-17. |
| Results | To consider and approve the Unaudited Financial Results for the quarter ended June 30, 2017. |
| Results | To consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2017. |
| Results | To consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2017, |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Indraprastha Medical Corporation Limited has informed the Exchange about Board Meeting to be held on 08-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Indraprastha Medical Corporation Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Other business matters | To consider other business matters |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Indraprastha Medical Corporation Limited
Voting Results of Indraprastha Medical Corporation Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 24-SEP-2024 | AGM | Adoption of financial statements for the financial year ended 31st March, 2024, together with the Report of the Board of Directors and Auditors thereon |
| 24-SEP-2024 | AGM | Ratification of remuneration of the Cost Auditor for the financial year ending 31st March, 2025. |
| 24-SEP-2024 | AGM | Payment of remuneration to the Non-Executive Directors including Independent Directors of the Company. |
| 24-SEP-2024 | AGM | re-appointment of Mr. Shivakumar Pattabhiraman (DIN 08570283) as Managing Director for a period of two years from 5th November, 2024 to 4th November, 2026. |
| 24-SEP-2024 | AGM | Continuation of Dr. Prathap C. Reddy (DIN 00003654) as a Non-Executive Director |
| 24-SEP-2024 | AGM | Re-apoointment of retiring Director in place of Dr. Sangita Reddy (DIN 00006285) who retires by rotation and being eligible has offered hereself for re-appointment |
| 24-SEP-2024 | AGM | Re-appointment of retiring Director in place of Prof. (Dr.) Mahesh Verma (DIN 08997324) who retires by rotation and being eligible has offered himself for re-appointment. |
| 24-SEP-2024 | AGM | Declaration of Dividend on Equity Shares for the financial year ended 31st March, 2024, at the rate of Rs. 4.50 per equity share (45%) of face value of Rs. 10/- each. |
| 24-APR-2024 | Postal Ballot | Appointment of Shri Sandip Somany (DIN 00053597) as an Independent Director for a period of five years from 1st April, 2024 to 31st March, 2029 |
| 24-APR-2024 | Postal Ballot | Appointment of Shri Tejpreet Singh Chopra (DIN 00317683) as an Independent Director for a period of five years from 1st April, 2024 to 31st March, 2029 |
| 21-SEP-2023 | AGM | Adoption of audited financial statements for the financial year ended on 31st March, 2023, Reports of the Board of Directors and auditors￢ﾀﾙ thereon. |
| 21-SEP-2023 | AGM | Ratification of remuneration to Cost Auditors of the Company for the financial year ending on 31st March, 2024. |
| 21-SEP-2023 | AGM | Appointment of a Director in place of Dr. Sangita Reddy (DIN:00006285) who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible offers herself for re-appointment. |
| 21-SEP-2023 | AGM | Appointment of a Director in place of Ms. Suneeta Reddy (DIN:00001873) who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible offers herself for re-appointment. |
| 21-SEP-2023 | AGM | Declaration of Dividend on Equity Shares for the Financial Year ended on 31st March, 2023 at the rate of Rs.3.00 per equity share (30%) of the face value of Rs.10/- each fully paid-up. |
| 23-SEP-2022 | AGM | Adoption of Audited Financial Statements of the Company for the Financial Year ended on 31st March, 2022, together with the Report of the Board of Directors and Auditors thereon |
| 23-SEP-2022 | AGM | Re-appointment of M/s S. N. Dhawan & Co. LLP, Chartered Accountants (ICAI Firm Registration No. 000050N/N500045) as Statutory Auditors of the Company for a period of five years |
| 23-SEP-2022 | AGM | Appointment of a Director in place of Mr. Vikram Bhat (DIN:09076418) who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible offers himself for re-appointment |
| 23-SEP-2022 | AGM | Appointment of a Director in place of Prof. (Dr.) Mahesh Verma (DIN:08997324) who retires by rotation in terms of section 152(6) of the Compnaies Act, 2013 and being eligible offers himself for re-appointment |
| 23-SEP-2022 | AGM | Declaration of Dividend on Equity Shares for the Financial Year ended on 31st March, 2022 at the rate of Rs.2.50/- per equity share (25%) of the face value of Rs.10/- each fully paid-up |
FAQs on Indraprastha Medical Corporation Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.